Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
The role of the circadian clock in Alzheimer's disease
FY 2015-16
Summary
Alzheimer's disease (AD), the most common form of dementia, is a progressive neurodegenerative disease that affects approximately half a million Canadians. There is a critical need for an understanding of the processes underlying AD that will lead to the development of new therapeutics for this disease. The circadian clock is an internal timekeeping system that produces daily (circadian) rhythms in physiological processes such as sleep and metabolism. The circadian system plays important roles in human physiology and disease and its disruption is thought to contribute to the development of AD. I propose to investigate the molecular mechanisms underlying the association between AD and circadian dysfunction by employing a proteomics approach allowing for the large-scale quantitative analysis of thousands of proteins. I will identify clock-dependent protein networks and pathways altered in an AD mouse model, focusing on the hippocampus, an area of the brain important in memory function. In addition, I will investigate the clock-dependent mechanisms responsible for the toxic effects of amyloid-beta, a key mediator of AD pathology. Given the insight from these studies, I will explore potential therapeutic strategies by assessing whether pharmacological modulation of circadian rhythms has an effect on the severity of memory deficits and brain pathology in this preclinical mouse model of AD. Knowledge gained from this project will enhance our understanding of the unique protein alterations in AD and might lead to the identification of potential targets for future translational studies for the prevention or treatment of this neurodegenerative disease.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
350107
Name
Adler Paula
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of the circadian clock in Alzheimer's disease
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer’S Disease; Circadian Rhythm; Hippocampus; Immunohistochemistry; Learning And Memory; Mass Spectrometry; Neurodegenerative Diseases; Quantitative Proteomics; Rodent Behaviour; Transgenic Mice
Abstract
Alzheimer's disease (AD), the most common form of dementia, is a progressive neurodegenerative disease that affects approximately half a million Canadians. There is a critical need for an understanding of the processes underlying AD that will lead to the development of new therapeutics for this disease. The circadian clock is an internal timekeeping system that produces daily (circadian) rhythms in physiological processes such as sleep and metabolism. The circadian system plays important roles in human physiology and disease and its disruption is thought to contribute to the development of AD. I propose to investigate the molecular mechanisms underlying the association between AD and circadian dysfunction by employing a proteomics approach allowing for the large-scale quantitative analysis of thousands of proteins. I will identify clock-dependent protein networks and pathways altered in an AD mouse model, focusing on the hippocampus, an area of the brain important in memory function. In addition, I will investigate the clock-dependent mechanisms responsible for the toxic effects of amyloid-beta, a key mediator of AD pathology. Given the insight from these studies, I will explore potential therapeutic strategies by assessing whether pharmacological modulation of circadian rhythms has an effect on the severity of memory deficits and brain pathology in this preclinical mouse model of AD. Knowledge gained from this project will enhance our understanding of the unique protein alterations in AD and might lead to the identification of potential targets for future translational studies for the prevention or treatment of this neurodegenerative disease.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Adler, Paula
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~